Clinical Trials Logo

Filter by:
NCT ID: NCT02211794 Active, not recruiting - Clinical trials for Degenerative Joint Disease

Journey II BCS EU Observational Trial

Start date: January 2014
Phase:
Study type: Observational

Post-market study to confirm the safety and efficacy of the Journey II BCS knee prosthesis.

NCT ID: NCT02205047 Active, not recruiting - Clinical trials for Malignant Neoplasm of Stomach

Neoadjuvant Study Using Trastuzumab or Trastuzumab With Pertuzumab in Gastric or Gastroesophageal Junction Adenocarcinoma

INNOVATION
Start date: July 15, 2015
Phase: Phase 2
Study type: Interventional

The purpose of this study is to find out whether either trastuzumab or the combination of trastuzumab and pertuzumab with standard chemotherapy shows more activity against gastro-oesophageal adenocarcinoma than standard chemotherapy given before and after surgery and it can be safely administered.

NCT ID: NCT02202785 Active, not recruiting - Clinical trials for Pancreatic Adenocarcinoma

A Study of MLN0264 in Patients With Pancreatic Cancer

Start date: July 2014
Phase: Phase 2
Study type: Interventional

The purpose of this study is to assess the efficacy, safety and tolerability of MLN0264 in patients with advanced or metastatic guanylyl cyclase C (GCC)-positive adenocarcinoma of the pancreas.

NCT ID: NCT02202759 Active, not recruiting - Clinical trials for Adenocarcinoma of the Stomach

A Study of MLN0264 in Patients With Cancer of the Stomach or Gastroesophageal Junction

Start date: July 2014
Phase: Phase 2
Study type: Interventional

The purpose of this study is to assess the efficacy, safety and tolerability of MLN0264 in patients with recurrent or metastatic guanylyl cyclase C (GCC)-positive adenocarcinoma of the stomach or gastroesophageal junction.

NCT ID: NCT02201641 Active, not recruiting - Reversible Pulpitis Clinical Trials

Efficacy of Calcium Silicate Pulp-capping; a Randomized Controlled Clinical Trial

Start date: July 2012
Phase: Phase 4
Study type: Interventional

This study aims to investigate the tooth nerve response to a recently introduced therapeutic filling material (calcium silicate cement) called Biodentine and to assess the quality of the overlying filling compared to another material (glass ionomer cement) called Fuji IX used more commonly. Also to compare the effectiveness of cone beam computed tomography x-rays compared to conventional periapical x-rays in detecting lesions around these teeth.

NCT ID: NCT02201108 Active, not recruiting - Multiple Sclerosis Clinical Trials

Efficacy, Safety and Pharmacokinetics of Teriflunomide in Pediatric Patients With Relapsing Forms of Multiple Sclerosis

TERIKIDS
Start date: July 16, 2014
Phase: Phase 3
Study type: Interventional

Primary Objective: To assess the effect of teriflunomide in comparison to placebo on disease activity measured by time to first clinical relapse after randomization in children and adolescents 10 to 17 years of age with relapsing forms of multiple sclerosis (MS). Secondary Objective: - To assess the effect of teriflunomide in comparison to placebo on disease activity/progression measured by brain magnetic resonance imaging (MRI) and on cognitive function. - To evaluate the safety and tolerability of teriflunomide in comparison to placebo. - To evaluate the pharmacokinetics (PK) of teriflunomide.

NCT ID: NCT02199600 Active, not recruiting - Clinical trials for Rheumatoid Arthritis

The Medacta International GMK Sphere Post-Marketing Surveillance Study

Start date: October 2012
Phase: N/A
Study type: Interventional

This is a Post-Marketing Surveillance of GMK Sphere knee prosthesis.

NCT ID: NCT02195739 Active, not recruiting - Smoking Cessation Clinical Trials

Nicotine Replacement Therapy and Cardiovascular Disease

Start date: September 2013
Phase: N/A
Study type: Observational

The aim of this study is to compare the cardiovascular disease event rate in smokers undertaking pharmacologically unaided smoking cessation attempts (the non-exposed group) with the event rate in smokers attempting smoking cessation assisted by pharmacological interventions - by nicotine replacement therapy (as any, or a combination, of: nasal spray, transdermal patches, inhaler or gum and tablets) or other pharmacological smoking cessation aids (e.g. bupropion [Zyban®] and varenicline [Champix®]) - in a representative UK primary care population.

NCT ID: NCT02195479 Active, not recruiting - Multiple Myeloma Clinical Trials

A Study of Combination of Daratumumab and Velcade (Bortezomib) Melphalan-Prednisone (DVMP) Compared to Velcade Melphalan-Prednisone (VMP) in Participants With Previously Untreated Multiple Myeloma

Start date: December 9, 2014
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine if the addition of daratumumab to velcade (bortezomib) melphalan-prednisone (VMP) will prolong progression-free survival (PFS) compared with VMP alone in participants with previously untreated multiple myeloma who are ineligible for high dose chemotherapy and autologous stem cell transplant (ASCT).

NCT ID: NCT02194842 Active, not recruiting - Prostate Cancer Clinical Trials

Phase III Radium 223 mCRPC-PEACE III

PEACE III
Start date: October 2015
Phase: Phase 3
Study type: Interventional

The primary objective of the trial is to assess if upfront combination of enzalutamide and Ra223 improves radiological progression-free survival (rPFS1) compared to enzalutamide single agent in CRPC patients metastatic to bone